Search

Search Results
Results 1501 - 1510 of 1662 for Ace
  • Celebrex Relief
    Drug - 16 May 2025
    Consumer Medicine Information (CMI) about Celebrex Relief intended for persons living in Australia.
  • Celaxib (New Formulation)
    Drug - 17 Apr 2025
    Consumer Medicine Information (CMI) about Celaxib (New Formulation) intended for persons living in Australia.
  • Celebrex
    Drug - 17 Mar 2025
    Consumer Medicine Information (CMI) about Celebrex intended for persons living in Australia.
  • Amlodipine/Valsartan/HCT Novartis
    Drug - 10 Sep 2024
    Consumer Medicine Information (CMI) about Amlodipine/Valsartan/HCT Novartis intended for persons living in Australia.
  • Exforge HCT
    Drug - 10 Sep 2024
    Consumer Medicine Information (CMI) about Exforge HCT intended for persons living in Australia.
  • Amlodipine/Valsartan Novartis
    Drug - 2 Sep 2024
    Consumer Medicine Information (CMI) about Amlodipine/Valsartan Novartis intended for persons living in Australia.
  • Exforge
    Drug - 2 Sep 2024
    Consumer Medicine Information (CMI) about Exforge intended for persons living in Australia.
  • Rapamune Tablets
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Rapamune Tablets intended for persons living in Australia.
  • Rapamune Oral Solution
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Rapamune Oral Solution intended for persons living in Australia.
  • Gaucher's Disease Diagnosis
    Health - 14 Jul 2023
    Gaucher’s disease is a genetically inherited disorder that causes a deficiency in the enzyme glucocerebrosidase. This enzyme is required to break down the fatty substance glucocerebroside.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback